Renoprotective Effect of Sitagliptin ( Dipeptidyl Peptidase- 4 Inhibitor) aganist Cisplatin Induced Nephrotoxicity in Mice
Amany shalaby & Hala Abdel Malek · Journal of Pharmaceutical Research International · 2014
Back Ground and Objectives: Despite the therapeutic benefits of cisplatin (CDDP), its use clinically is often limited due to dose-related nephrotoxicity. On the meanwhile, DPP 4 inhibitors could attenuate kidney injury, so in the present work, it was aimed to investigate the effe...
Open access
Research Article
10.9734/BJPR/2014/9297